1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ADAM9 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA ME2 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA MLLT1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA USP27X CTRPv2 pan-cancer AAC 0.11 0.001
mRNA FAM3B CTRPv2 pan-cancer AAC 0.1 0.001
mRNA DHX33 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA STIM1 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA FGD1 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA THAP8 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA AC007906.1 CTRPv2 pan-cancer AAC 0.11 0.001
Download CSV